FC20 Automating psoriasis area and severity index assessment from real-world images using Vision Transformers

Abstract The psoriasis area and severity index (PASI) is the gold standard for assessing psoriasis severity but is time-consuming, subjective, poorly reproducible, and requires face-to-face interaction between clinician and patient. Automating PASI assessments using deep learning-based image analysis may provide a more objective, efficient measure of disease severity in trial and real-world settings. Most studies have used Convolutional Neural Networks.1 However, Vision Transformers (ViTs) are sophisticated deep learning models that have shown unprecedented capabilities in image analysis, including classifying skin lesions from dermoscopic images and 3D image (computed tomography/magnetic resonance imaging scan) analysis. We sought to develop and evaluate a ViT model for automated PASI using images. Following consent, adults with chronic plaque psoriasis were recruited via a UK national specialized psoriasis service (04/2021–05/2024). Professional studio photographs (five standardized views) and self-taken photographs (three views) were captured. Two blinded, independent face-to-face physician PASI measures were recorded, with the first rater used as the primary reference value. Fitzpatrick Skin Type and Physician Global Assessment (PGA) were also noted. We trained our ‘MultiViT’ model over 300 epochs and tested using an 80:20 split of the participants. MultiViT advances beyond standard ViTs by handling multiple images and resolutions simultaneously. Mean absolute error (MAE) was used to assess prediction accuracy and compare the standard ViT models with the MultiViT. We captured 1109 images from 152 participants; 63% were male, median age of 45.5 years [interquartile range (IQR) 33.75–57.0], median body mass index of 29.68, 84% Fitzpatrick Skin Types I–IV, and 16% V and VI. The majority (76%) had mild-to-moderate disease (PGA ≤3); median PASI was 8.2 (IQR 5.7–12.7). The MultiViT model demonstrated an MAE of 3.88 for predicting PASI from skin images vs. 5.13 for the standard ViT. When stratified by skin type, I–IV performed better than V and VI (MAE of 2.80 and 8.17, respectively), and by disease severity, PGA ≤3 performed better than PGA >3 (MAE of 1.97 and 9.13, respectively). Our findings suggest the MultiViT model offers potential for automated psoriasis severity assessments from skin images, with favourable prediction accuracy despite a small dataset. An expanded and more diverse (Fitzpatrick Skin Type, severity) dataset will enable further refinement, validation and testing of the MultiViT model in trial and real-world settings. Future integration into a smartphone application will facilitate self-monitoring of psoriasis and healthcare efficiency for improved health and cost outcomes in psoriasis.

Publication Details

Journal
British Journal of Dermatology
Published
2024-12-01
DOI
https://doi.org/10.1093/bjd/ljae360.020
Primary Topic
Psoriasis: Treatment and Pathogenesis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

FC20 Automating psoriasis area and severity index assessment from real-world images using Vision Transformers

British Journal of Dermatology
Psoriasis: Treatment and Pathogenesis
article

FC20 Automating psoriasis area and severity index assessment from real-world images using Vision Transformers

article en

Abstract

Abstract The psoriasis area and severity index (PASI) is the gold standard for assessing psoriasis severity but is time-consuming, subjective, poorly reproducible, and requires face-to-face interaction between clinician and patient. Automating PASI assessments using deep learning-based image analysis may provide a more objective, efficient measure of disease severity in trial and real-world settings. Most studies have used Convolutional Neural Networks.1 However, Vision Transformers (ViTs) are sophisticated deep learning models that have shown unprecedented capabilities in image analysis, including classifying skin lesions from dermoscopic images and 3D image (computed tomography/magnetic resonance imaging scan) analysis. We sought to develop and evaluate a ViT model for automated PASI using images. Following consent, adults with chronic plaque psoriasis were recruited via a UK national specialized psoriasis service (04/2021–05/2024). Professional studio photographs (five standardized views) and self-taken photographs (three views) were captured. Two blinded, independent face-to-face physician PASI measures were recorded, with the first rater used as the primary reference value. Fitzpatrick Skin Type and Physician Global Assessment (PGA) were also noted. We trained our ‘MultiViT’ model over 300 epochs and tested using an 80:20 split of the participants. MultiViT advances beyond standard ViTs by handling multiple images and resolutions simultaneously. Mean absolute error (MAE) was used to assess prediction accuracy and compare the standard ViT models with the MultiViT. We captured 1109 images from 152 participants; 63% were male, median age of 45.5 years [interquartile range (IQR) 33.75–57.0], median body mass index of 29.68, 84% Fitzpatrick Skin Types I–IV, and 16% V and VI. The majority (76%) had mild-to-moderate disease (PGA ≤3); median PASI was 8.2 (IQR 5.7–12.7). The MultiViT model demonstrated an MAE of 3.88 for predicting PASI from skin images vs. 5.13 for the standard ViT. When stratified by skin type, I–IV performed better than V and VI (MAE of 2.80 and 8.17, respectively), and by disease severity, PGA ≤3 performed better than PGA >3 (MAE of 1.97 and 9.13, respectively). Our findings suggest the MultiViT model offers potential for automated psoriasis severity assessments from skin images, with favourable prediction accuracy despite a small dataset. An expanded and more diverse (Fitzpatrick Skin Type, severity) dataset will enable further refinement, validation and testing of the MultiViT model in trial and real-world settings. Future integration into a smartphone application will facilitate self-monitoring of psoriasis and healthcare efficiency for improved health and cost outcomes in psoriasis.

British Journal of DermatologyVol. 191(Supplement_3)
Good health and well-being
Openalex Percentile: Top 71%
Psoriasis: Treatment and Pathogenesis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.